Form 4: Boston Scientific Director Habiger Receives Equity Award, Disposes of Shares

Director David C. Habiger of Boston Scientific Corp. received an annual equity award and disposed of shares on May 8, 2025.

Summary

• On May 8, 2025, David C. Habiger, a director of Boston Scientific Corp., acquired 2,081 shares of common stock through an annual equity award.
• The award is in the form of restricted stock that vests fully upon the next annual meeting of stockholders.
• The price of the acquired shares was $0.00.
• Habiger also disposed of 5,628 shares of common stock.
• Following these transactions, Habiger beneficially owns 5,628 shares of Boston Scientific Corp.
• The reporting person has signed the document on May 9, 2025.

Sentiment

Score: 5

Explanation: The document is a routine filing of stock transactions by a company director. The sentiment is neutral as it simply reports facts without expressing any opinion or forward-looking statements that would indicate a positive or negative outlook.

Positives

• The equity award to a director aligns their interests with those of the shareholders.

Negatives

• The disposal of 5,628 shares by the director could be interpreted negatively by some investors, although the reason for disposal is not specified.

Future Outlook

The restricted stock vests upon the next annual meeting of stockholders, indicating a future event tied to the company's performance and shareholder engagement.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Comparison to Industry Standards

• Equity awards are a common form of compensation for directors in publicly traded companies like Boston Scientific.
• Companies such as Medtronic (MDT) and Abbott Laboratories (ABT) also utilize equity awards as part of their director compensation packages.
• The vesting schedule tied to the annual meeting is a typical structure to align director interests with shareholder value.

Stakeholder Impact

• The equity award aligns the director's interests with those of the shareholders.
• The disposal of shares could be perceived negatively by shareholders if not properly understood.

Next Steps

• The restricted stock will vest upon the next annual meeting of stockholders.

Key Dates

Keywords

Form 4, Beneficial Ownership, Equity Award, Director, BSX, Boston Scientific, Habiger